The project CE4BIG – Cluster Excellence for Business Innovation and Growth in the Health Sector – funded under the EU... View Article
Author Archives for Adeline Chauvigné
CE4BIG: Launch of the ClusterXchange Scheme!
13 May 2025The project CE4BIG – Cluster Excellence for Business Innovation and Growth in the Health Sector – funded under the EU... View Article
Valneva’s Chikungunya Vaccine Candidate Awarded EMA Prime Designation
Valneva SE a specialty vaccine company focused on prevention of diseases with major unmet needs, today announced that the European... View Article
Valneva’s Chikungunya Vaccine Candidate Awarded EMA Prime Designation
13 May 2025Valneva SE a specialty vaccine company focused on prevention of diseases with major unmet needs, today announced that the European... View Article
ProfileHIT develops a STOP-COVID19 research program’s
As part of the R&D effort provided since March 2020 by biotech companies located in Nantes in order to fight... View Article
ProfileHIT develops a STOP-COVID19 research program’s
13 May 2025As part of the R&D effort provided since March 2020 by biotech companies located in Nantes in order to fight... View Article
New member | Satisform
Satisform is a French company based in Le Mans. It designs and produces medical devices used in rehabilitation and preventive... View Article
New member | Satisform
13 May 2025Satisform is a French company based in Le Mans. It designs and produces medical devices used in rehabilitation and preventive... View Article
OSE Immunotherapeutics Receives European Patent Notice of Allowance for First-in-Class CD28-Antagonist Immunotherapy FR104
The patent covers novel dosing regimen of FR104 in Europe through 2036 for therapeutic applications in autoimmune diseases, inflammatory diseases,... View Article
OSE Immunotherapeutics Receives European Patent Notice of Allowance for First-in-Class CD28-Antagonist Immunotherapy FR104
13 May 2025The patent covers novel dosing regimen of FR104 in Europe through 2036 for therapeutic applications in autoimmune diseases, inflammatory diseases,... View Article
Ceva builds on its preventative health strategy with opening of a new european reference for the manufacture of autogenous vaccines
An innovative project confirms Ceva’s commitment to improving preventative animal health and reducing the use of antibiotics. Beaucouzé, 29 September... View Article
Ceva builds on its preventative health strategy with opening of a new european reference for the manufacture of autogenous vaccines
13 May 2025An innovative project confirms Ceva’s commitment to improving preventative animal health and reducing the use of antibiotics. Beaucouzé, 29 September... View Article
New member | Divoluci
Divoluci is an innovative tool to orientate patients between health professionals in order to ameliorate relationships between local medicine care... View Article
New member | Divoluci
13 May 2025Divoluci is an innovative tool to orientate patients between health professionals in order to ameliorate relationships between local medicine care... View Article
#Coronavirus | Xenothera: phase 2A clinical trial is launched
Since August, the POLYCOR trial has been officially launched in France. It will eventually bring together some thirty hospitals volunteering... View Article
#Coronavirus | Xenothera: phase 2A clinical trial is launched
13 May 2025Since August, the POLYCOR trial has been officially launched in France. It will eventually bring together some thirty hospitals volunteering... View Article
The first in France: the University Hospital of Rennes has deployed the 1st comprehensive digital pathology system, thanks to the NOMINOË fund
The Nominoë Fund, an endowment fund for the University Hospital of Rennes, has enabled the Pathological Anatomy and Cytology Department... View Article
The first in France: the University Hospital of Rennes has deployed the 1st comprehensive digital pathology system, thanks to the NOMINOË fund
13 May 2025The Nominoë Fund, an endowment fund for the University Hospital of Rennes, has enabled the Pathological Anatomy and Cytology Department... View Article
Atlanpole Biotherapies is enjoying sustained dynamic growth and is committed to addressing the challenges of France’s independence in terms of health
The competitiveness cluster is experiencing exponential growth, and currently has 210 members. The 2019 target of increasing the number... View Article
Atlanpole Biotherapies is enjoying sustained dynamic growth and is committed to addressing the challenges of France’s independence in terms of health
13 May 2025The competitiveness cluster is experiencing exponential growth, and currently has 210 members. The 2019 target of increasing the number... View Article